We are live on ! Find out more
SIM

Spark Investment Management Portfolio holdings

AUM $41.6M
1-Year Est. Return 80.97%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+80.97%
3 Year Est. Return
+336.74%
5 Year Est. Return
+318.26%
10 Year Est. Return
+1,447.76%
AUM
$716M
AUM Growth
-$455K
Cap. Flow
+$5.83M
Cap. Flow %
0.81%
Top 10 Hldgs %
9.92%
Holding
851
New
153
Increased
123
Reduced
163
Closed
191

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$5.66M
2
GIMO
Gigamon Inc.
GIMO
+$4.46M
3
SONC
Sonic Corp
SONC
+$3.7M
4
CDK
CDK Global, Inc.
CDK
+$3.56M
5
APTV icon
Aptiv
APTV
+$3.19M

Top Sells

Rank Stock Value
1
ARUN
ARUBA NETWORKS, INC.
ARUN
+$5.17M
2
ABBV icon
AbbVie
ABBV
+$4.29M
3
OCUL icon
Ocular Therapeutix
OCUL
+$3.67M
4
LRMR icon
Larimar Therapeutics
LRMR
+$2.88M
5
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 20.73%
2 Healthcare 19.83%
3 Consumer Discretionary 15.89%
4 Industrials 11.34%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNCE
76
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.55M 0.36%
171,400
+69,100
+68% +$1.05M
IRWD icon
77
Ironwood Pharmaceuticals
IRWD
$701M
$2.51M 0.35%
+248,830
New +$2.89M
EW icon
78
Edwards Lifesciences
EW
$51.5B
$2.49M 0.35%
105,000
– –
STLA icon
79
Stellantis
STLA
$20.9B
$2.48M 0.35%
+261,958
New +$2.69M
MENT
80
DELISTED
Mentor Graphics Corp
MENT
$2.48M 0.35%
93,900
– –
DCH
81
Dauch Corp
DCH
$1.35B
$2.48M 0.35%
118,600
– –
PLCM
82
DELISTED
POLYCOM INC
PLCM
$2.47M 0.34%
215,400
– –
CLS icon
83
Celestica
CLS
$36.2B
$2.43M 0.34%
209,000
– –
GEN icon
84
Gen Digital
GEN
$16.8B
$2.42M 0.34%
104,300
-38,800
-27% -$947K
MSTR icon
85
Strategy Inc
MSTR
$37.2B
$2.41M 0.34%
142,000
– –
CPHD
86
DELISTED
Cepheid Inc
CPHD
$2.41M 0.34%
+39,400
New +$2.25M
AEGR
87
DELISTED
Aegerion Pharmaceuticals
AEGR
$2.4M 0.34%
+126,800
New +$2.74M
FISV
88
Fiserv Inc
FISV
$28.9B
$2.38M 0.33%
57,400
-25,600
-31% -$1.03M
ITRI icon
89
Itron
ITRI
$4.5B
$2.35M 0.33%
68,400
-12,600
-16% -$457K
BLCM
90
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.35M 0.33%
+11,050
New +$2.71M
FICO icon
91
Fair Isaac
FICO
$22.3B
$2.31M 0.32%
25,500
– –
BIO icon
92
Bio-Rad Laboratories Class A
BIO
$9.16B
$2.23M 0.31%
14,800
-5,200
-26% -$744K
TAL
93
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$2.22M 0.31%
70,400
– –
PTC icon
94
PTC
PTC
$16B
$2.22M 0.31%
54,200
– –
MOH icon
95
Molina Healthcare
MOH
$10B
$2.2M 0.31%
31,300
– –
KWR icon
96
Quaker Houghton
KWR
$2.88B
$2.19M 0.31%
24,600
+4,700
+24% +$405K
MLNX
97
DELISTED
Mellanox Technologies, Ltd.
MLNX
$2.17M 0.3%
44,700
+28,800
+181% +$1.4M
DHX icon
98
DHI Group
DHX
$178M
$2.16M 0.3%
242,600
– –
FAF icon
99
First American
FAF
$7.67B
$2.15M 0.3%
57,900
– –
RXDX
100
DELISTED
Ignyta, Inc.
RXDX
$2.15M 0.3%
142,700
+116,400
+443% +$1.41M
2 3
4
5 6

Similar funds

ACM
Altium Capital Management New York $42M AUM
TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
CF
Crosspoint Financial Tustin, California $39.8M AUM 14.13% 1-Year Est. Return

Spark Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Spark Investment Management held 851 positions worth $716M, down 0.06% from $716M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Spark Investment Management's Q2 2015 filing shows 153 new, 123 increased, 163 reduced and 191 closed positions. Its largest new stake was bluebird bio: 2,779 shares worth $6.06M. The largest sale was ARUBA NETWORKS, INC., an estimated $5.17M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Spark Investment Management's largest Q2 2015 buy was bluebird bio: 2,779 shares worth $6.06M.
  • Spark Investment Management added most to Gigamon Inc. in Q2 2015, an estimated $4.46M increase.
  • Spark Investment Management's biggest Q2 2015 reduction was Larimar Therapeutics, cutting an estimated $2.88M.
  • Spark Investment Management fully exited ARUBA NETWORKS, INC. in Q2 2015, selling an estimated $5.17M.
  • Spark Investment Management's ten largest holdings make up 9.9% of its $716M portfolio in Q2 2015.
  • Spark Investment Management opened 153 new positions and closed 191 in Q2 2015.
  • Spark Investment Management's portfolio value fell 0.06% quarter-over-quarter to $716M.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.